MARKET

RGEN

RGEN

Repligen
NASDAQ
142.44
-2.93
-2.02%
After Hours: 141.55 -0.89 -0.62% 17:54 03/13 EDT
OPEN
145.18
PREV CLOSE
145.37
HIGH
146.65
LOW
140.93
VOLUME
462.36K
TURNOVER
--
52 WEEK HIGH
200.23
52 WEEK LOW
113.50
MARKET CAP
7.98B
P/E (TTM)
-312.2999
1D
5D
1M
3M
1Y
5Y
1D
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Barchart · 2d ago
Weekly Report: what happened at RGEN last week (0303-0307)?
Weekly Report · 3d ago
Repligen’s Strategic Acquisition of 908 Devices’ Assets: A Buy Rating for Long-term Shareholder Value
TipRanks · 3d ago
3 Small-Cap Stocks Skating on Thin Ice
Barchart · 03/06 08:00
Repligen’s Strategic Acquisition: Hold Rating Amid Short-term Financial Dilution and Long-term Growth Potential
TipRanks · 03/05 11:47
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Benzinga · 03/04 18:26
Repligen deal can expand bioprocessing opportunities, says RBC Capital
TipRanks · 03/04 18:01
Repligen Expands Bioprocessing Analytics Portfolio With Acquisition Of Desktop Devices
NASDAQ · 03/04 17:10
More
About RGEN
More
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Recently
Symbol
Price
%Change

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.